Molecular Detection of Ofloxacin and Kanamycin Resistance in Patients with MDR and Non-MDR TB from Suburban Districts in Hangzhou, China, 2019-2020

Biomed Environ Sci. 2022 May 20;35(5):468-471. doi: 10.3967/bes2022.064.

Authors

Affiliations

¹ Department of TB Control and Prevention, Hangzhou Center for Disease Control and Prevention, Hangzhou 310021, Zhejiang, China.
² Department of Pathology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang, China.

PMID: 35676819
DOI: 10.3967/bes2022.064

No abstract available

Publication types

Letter

MeSH terms

Antitubercular Agents / therapeutic use
China / epidemiology
Drug Resistance, Multiple, Bacterial
Extensively Drug-Resistant Tuberculosis*
Humans
Kanamycin Resistance
Microbial Sensitivity Tests
Mycobacterium tuberculosis*
Ofloxacin / pharmacology
Tuberculosis, Multidrug-Resistant* / drug therapy
Tuberculosis, Multidrug-Resistant* / epidemiology

Substances

Antitubercular Agents
Ofloxacin